Fig. 1From: The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetesMean fasting capillary glucose on self-monitoring during each week of therapy in the 3 treatment arms (data are presented as mean with standard error)Back to article page